Farnaz Absalan is a prominent inventor based in San Francisco, California. She has made significant contributions to the field of digital microfluidics, particularly in the area of single-cell isolation and characterization of analytes. With a total of three patents to her name, her work is paving the way for advancements in biomedical research and diagnostics.

Latest Patents

One of her latest patents is a digital microfluidic system designed for single-cell isolation and characterization of analytes. This innovative method involves utilizing a droplet actuator to transport a sample droplet to a microwell device. The microwell device features a substrate with multiple microwells that open onto a droplet operations surface. The sample droplet contains cells of interest that enter the microwells. The method also introduces capture beads to the microwells, where capture elements are immobilized. Furthermore, the droplet actuator transports a cell lysis reagent droplet to the microwell device. Portions of this reagent enter the microwells, causing the cells to release analytes that are captured by the elements on the beads.

Career Highlights

Farnaz Absalan is currently employed at Illumina Corporation, a leading company in the field of genomics and biotechnology. Her work at Illumina has allowed her to further develop her innovative ideas and contribute to groundbreaking research in the life sciences.

Collaborations

Throughout her career, Farnaz has collaborated with notable colleagues, including Gordon M. Cann and Arash Jamshidi. These collaborations have enriched her research and expanded the impact of her inventions.

Conclusion

Farnaz Absalan's contributions to the field of digital microfluidics and her innovative patents are making a significant impact in biomedical research. Her work exemplifies the importance of innovation in advancing scientific knowledge and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.